Schizophrenia is a complex, chronic mental health disorder whose heterogeneous genetic
and neurobiological background influences early brain development, and whose precise …

Schizophrenia is regarded as a neurodevelopmental disorder with its course progressing
throughout life. However, the aetiology and development of schizophrenia are still under …

Neutrophil–lymphocyte ratio (NLR), platelet–lymphocyte ratio (PLR), monocyte–lymphocyte
ratio (MLR) and systemic immune-inflammation index (SII index) are increasingly used as …

Non-motor symptoms (NMS) are common among patients with Parkinson's disease and
reduce patients' quality of life (QOL). However, there remain considerable unmet needs for …

Clinicians and researchers consider that there are a variety of symptoms that constitute
negative symptoms in schizophrenia, and they may use different definitions for the same …

Background: Sex and gender differences have been reported in the prevalence, expression,
treatment response, and outcome of schizophrenia, but most reports are based on relatively …

Schizophrenia pathogenesis remains challenging to define; however, there is strong
evidence that the interaction of genetic and environmental factors causes the disorder. This …

Background: The dopaminergic theory, the oldest and most comprehensively analyzed
neurotransmitter theory of schizophrenia, remains a focal point of research. Methods: This …

Methamphetamine use disorder (MAUD) can substantially jeopardize public security due to
its high‐risk social psychology and behaviour. Given that the dopamine reward system is …

Objective Anhedonia is a common symptom of depression, but is also a negative symptom
of schizophrenia. The purpose of this study was to examine the effects of vortioxetine on …